
Sign up to save your podcasts
Or


CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomic information and guide personalized cancer treatment.
By John Simboli5
77 ratings
CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomic information and guide personalized cancer treatment.

3,072 Listeners

1,982 Listeners

1,095 Listeners

2,370 Listeners

950 Listeners

800 Listeners

124 Listeners

338 Listeners

6,090 Listeners

92 Listeners

10,182 Listeners

571 Listeners

149 Listeners

249 Listeners

188 Listeners